Swine Flu Helps Biotech Stock

Among the few notable exceptions to the Dow’s generally down day on Monday was Foster City’s Gilead Sciences Inc., which climbed nearly 4 percent to close at $47.53. Could have something to do with the royalties they’re collecting on Tamiflu, the influenza drug the biotech company invented and sold to Swiss pharma Roche Holding AG [...]